131 related articles for article (PubMed ID: 35797545)
1. Lymph Node Ratio Improves Prediction of Overall Survival in Esophageal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy: A National Cancer Database Analysis.
Zhang Y; Cao Y; Zhang J; Huang M; Roy P; Huang B; Yang H; Rong Y; Chen Y; Zhu C; Fang W; Yu Z; Mao W; Xiang J; Han Y; Lin J; Zhang J; Fu J; He J; Li H
Ann Surg; 2023 Jun; 277(6):e1239-e1246. PubMed ID: 35797545
[TBL] [Abstract][Full Text] [Related]
2. A Novel Tumor Staging System Incorporating Tumor Regression Grade (TRG) With Lymph Node Status (ypN-Category) Results in Better Prognostication Than ypTNM Stage Groups After Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma.
Wong IYH; Chung JCY; Zhang RQ; Gao X; Lam KO; Kwong DLW; Chao YK; Law SYK
Ann Surg; 2022 Nov; 276(5):784-791. PubMed ID: 35876374
[TBL] [Abstract][Full Text] [Related]
3. Lymph node ratio as best prognostic factor in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy.
De la Cruz-Ku GA; Chambergo-Michilot D; Valcarcel B; Rebaza P; Möller M; Araujo JM; Enriquez D; Morante Z; Razuri C; Luque R; Saavedra A; Eyzaguirre E; Lujan M; Noel N; Pinto J; Cotrina J; Gomez H
Breast J; 2020 Sep; 26(9):1659-1666. PubMed ID: 32713113
[TBL] [Abstract][Full Text] [Related]
4. Identification of Optimal Parameters for Assessing Lymph Node Status of Patients with Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy.
Huang X; Jiang D; Jian Z; Zeng Z; Zhang S; Fan H; Sun T; Tang H; Hou Y; Tan L
Ann Surg Oncol; 2024 Feb; 31(2):883-891. PubMed ID: 38038788
[TBL] [Abstract][Full Text] [Related]
5. External Validation of Pretreatment Pathological Tumor Extent in Patients with Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer.
Brinkmann S; Noordman BJ; Hölscher AH; Biermann K; van Klaveren D; Bollschweiler E; Pütz K; van Lanschot JJB; Drebber U
Ann Surg Oncol; 2020 Apr; 27(4):1250-1258. PubMed ID: 31691114
[TBL] [Abstract][Full Text] [Related]
6. Proposed modification of the eighth edition of the AJCC-ypTNM staging system of esophageal squamous cell cancer treated with neoadjuvant chemotherapy: Unification of the AJCC staging system and the Japanese classification.
Oshikiri T; Goto H; Kato T; Sawada R; Harada H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Fujino Y; Tominaga M; Kakeji Y
Eur J Surg Oncol; 2022 Aug; 48(8):1760-1767. PubMed ID: 35094909
[TBL] [Abstract][Full Text] [Related]
7. Validation of the post-neoadjuvant staging system of the American joint committee on cancer, 8th edition, in patients treated with neoadjuvant chemoradiotherapy followed by curative esophagectomy for localized esophageal squamous cell carcinoma.
Kang J; Lee HP; Kim HR; Kim JH; Jung HY; Lee GH; Song HJ; Kim DH; Choi KD; Ahn JY; Ryu JS; Cho KJ; Lee MY; Kim SB; Kim YH; Park SR
Surg Oncol; 2020 Dec; 35():491-497. PubMed ID: 33130441
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of axillary lymph node status after neoadjuvant chemotherapy. Results from a multicentre study.
Saxena N; Hartman M; Aziz R; Rapiti E; Bhoo Pathy N; Lim SE; Iau P; Taib NA; Schaffar R; Neyroud-Caspar I; Yip CH; Lee SC; Verkooijen HM
Eur J Cancer; 2011 May; 47(8):1186-92. PubMed ID: 21239165
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of Lymph Node Ratio in Breast Cancer Patients with Adequate Pathologic Evidence After Neoadjuvant Chemotherapy.
Ai X; Liao X; Wang M; Hu Y; Li J; Zhang Y; Tang P; Jiang J
Med Sci Monit; 2020 Apr; 26():e922420. PubMed ID: 32348295
[TBL] [Abstract][Full Text] [Related]
10. Lymph node ratio is an independent prognostic factor in node positive rectal cancer patients treated with preoperative chemoradiotherapy followed by curative resection.
Zeng WG; Zhou ZX; Wang Z; Liang JW; Hou HR; Zhou HT; Zhang XM; Hu JJ
Asian Pac J Cancer Prev; 2014; 15(13):5365-9. PubMed ID: 25041003
[TBL] [Abstract][Full Text] [Related]
11. Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer.
Cao J; Yuan P; Ma H; Ye P; Wang Y; Yuan X; Bao F; Lv W; Hu J
Ann Thorac Surg; 2016 Aug; 102(2):424-32. PubMed ID: 27180928
[TBL] [Abstract][Full Text] [Related]
12. Lymph node ratio-based the ypTNrM staging system for gastric cancer after neoadjuvant therapy: a large population-based study.
Chen JX; Sun JW; Wang Y; Pan T; Zhuang LP; Lin LZ; Lv BC
Surg Today; 2022 May; 52(5):783-794. PubMed ID: 34724107
[TBL] [Abstract][Full Text] [Related]
13. Lymph node ratio-based staging system for esophageal squamous cell carcinoma.
Chen SB; Weng HR; Wang G; Zou XF; Liu DT; Chen YP; Zhang H
World J Gastroenterol; 2015 Jun; 21(24):7514-21. PubMed ID: 26139998
[TBL] [Abstract][Full Text] [Related]
14. The prognostic significance of the treatment response of regional lymph nodes and the refinement of the current TNM staging system in locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
Cui J; Zhang L; Yang L; Zhu YL; Fang H; Chen B; Ning Y; Zhang HZ
Cancer Med; 2020 Dec; 9(24):9373-9384. PubMed ID: 33079470
[TBL] [Abstract][Full Text] [Related]
15. Metastatic lymph node ratio demonstrates better prognostic stratification than pN staging in patients with esophageal squamous cell carcinoma after esophagectomy.
Zhang H; Liang H; Gao Y; Shang X; Gong L; Ma Z; Sun K; Tang P; Yu Z
Sci Rep; 2016 Dec; 6():38804. PubMed ID: 27941828
[TBL] [Abstract][Full Text] [Related]
16. Applying post-neoadjuvant pathologic stage as prognostic tool in esophageal squamous cell carcinoma.
Han W; Deng W; Wang Q; Ni W; Li C; Zhou Z; Liang J; Chen D; Feng Q; Bi N; Zhang T; Wang X; Deng L; Wang W; Liu W; Wang J; Xue Q; Mao Y; Liu X; Fang D; Li J; Wang D; Zhao J; Xiao Z
Front Oncol; 2022; 12():998238. PubMed ID: 36439431
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a nomogram incorporating axillary lymph node ratio to predict survival in node-positive breast cancer patients after neoadjuvant chemotherapy.
Lai J; Pan Z; Chen P; Ye G; Chen K; Su F
Jpn J Clin Oncol; 2019 Jan; 49(1):22-28. PubMed ID: 30508184
[TBL] [Abstract][Full Text] [Related]
18. Lymph node ratio is a prognostic indicator for locally advanced esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy.
Chen P; Wang L; Yang X; Feng J
Biomol Biomed; 2024 Jan; 24(1):159-169. PubMed ID: 37597214
[TBL] [Abstract][Full Text] [Related]
19. Tumor regression grade combined with lymph node status in esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy.
Yun JK; Kim Y; Lee GD; Choi S; Kim YH; Kim DK; Park SI; Kim HR
Cancer Med; 2022 Oct; 11(19):3623-3632. PubMed ID: 35434935
[TBL] [Abstract][Full Text] [Related]
20. Comparison of different lymph node staging schemes in prostate cancer patients with lymph node metastasis.
Jin S; Wang J; Shen Y; Gan H; Xu P; Wei Y; Wei J; Wu J; Wang B; Wang J; Yang C; Zhu Y; Ye D
Int Urol Nephrol; 2020 Jan; 52(1):87-95. PubMed ID: 31552575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
